Search





Search





Maia Biotechnology Inc

MAIA

Add to Watchlist

1.410USD

-0.010-0.70%

Close 08-10 16:00（ET）Quotes delayed by 15 min

85.73MMarket Cap

LossP/E TTM

Maia Biotechnology Inc

1.410

-0.010-0.70%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

MAIA Cash Flow Statement

You can access the annual and quarterly cash flow statements of Maia Biotechnology Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q1

FY2020Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-63.23%-6.75M

-26.39%-5.31M

-79.64%-7.02M

1.08%-3.49M

11.73%-4.14M

-17.16%-4.20M

2.11%-3.91M

-11.64%-3.52M

-82.95%-4.68M

-6.73%-3.59M

-59.10%-3.99M

26.90%-3.16M

-12.23%-2.56M

-32.01%-3.36M

-56.13%-2.51M

---4.32M

---2.28M

-904.96%-2.55M

-486.02%-1.61M

---253.31K

---274.26K

Net income from continuing operations

-48.56%-7.94M

-41.01%-6.37M

-1.59%-3.63M

-225.41%-8.90M

39.78%-5.35M

44.01%-4.52M

42.91%-3.57M

43.89%-2.74M

-96.29%-8.88M

-95.96%-8.07M

-22.27%-6.26M

-23.99%-4.88M

-36.84%-4.52M

-20.59%-4.12M

-623.62%-5.12M

---3.93M

---3.31M

-234.19%-3.41M

78.69%-707.14K

---1.02M

---3.32M

Other non-cash items

-16.77%268.76K

74.42%-211.30K

109.20%115.67K

84.41%-192.00K

-93.74%322.92K

-119.70%-825.99K

-8569.08%-1.26M

-797.85%-1.23M

589.55%5.16M

1193.71%4.19M

-101.45%-14.50K

--176.44K

--747.95K

---383.36K

1550.02%1.00M

--0.00

100.00%0.00

-80.48%-69.03K

---61.55K

---38.25K

Change in working capital

132.96%200.85K

-19.48%619.60K

-2001.63%-4.32M

38773.19%4.96M

106.20%86.22K

1338.97%769.50K

-75.23%227.08K

-101.32%-12.83K

-333.16%-1.39M

-110.32%-62.11K

-17.99%916.78K

205.66%971.10K

35.60%596.12K

288.94%602.06K

50.96%1.12M

---919.11K

--439.60K

-40.82%154.80K

-20.71%740.50K

--261.57K

--933.92K

-Change in receivables

----

--71.86K

---71.86K

----

-Change in prepaid expenses

153.48%264.88K

130.02%137.11K

-860.19%-238.95K

104.86%11.44K

277.43%104.50K

-780.79%-456.75K

-79.28%31.43K

-34.65%-235.57K

-137.92%-58.89K

-56.37%67.09K

262.91%151.69K

16.42%-174.94K

326.85%155.31K

214.47%153.78K

-571.54%-93.11K

---209.32K

---68.47K

-403.20%-134.34K

-150.95%-13.87K

--44.31K

--27.21K

-Change in payables and accrued expense

----

--31.83K

-Change in other current assets

----

324.95%80.41K

----

-120.55%-35.75K

-51.36%129.20K

54.61%-18.05K

63.70%-18.60K

-104.04%-16.21K

507.95%265.62K

75.91%-39.77K

-16013.98%-51.24K

399.26%401.17K

---65.11K

---165.08K

100.47%322.00

---134.06K

---68.56K

--0.00

-Change in other current liabilities

----

-100.00%0.00

----

---3.06K

-97.55%3.06K

-100.00%0.00

--125.00K

Cash from non-recurring investing activities

Cash from operating activities

-63.23%-6.75M

-26.39%-5.31M

-79.64%-7.02M

1.08%-3.49M

11.73%-4.14M

-17.16%-4.20M

2.11%-3.91M

-11.64%-3.52M

-82.95%-4.68M

-6.73%-3.59M

-59.10%-3.99M

26.90%-3.16M

-12.23%-2.56M

-32.01%-3.36M

-56.13%-2.51M

---4.32M

---2.28M

-904.96%-2.55M

-486.02%-1.61M

---253.31K

---274.26K

Investing cash flow

Cash from non-current investing activities

Financing cash flow

Cash flow from continuous financing activities

-101.91%-65.00K

468.60%31.05M

-0.89%4.80M

575.60%4.23M

-57.33%3.41M

15.78%5.46M

-3.58%4.85M

397.71%626.82K

93.89%7.99M

--4.72M

893.55%5.03M

-98.71%125.94K

997.37%4.12M

-100.00%0.00

-151.53%-633.28K

--9.76M

--375.40K

4.19%2.53M

352.90%1.23M

--2.43M

--271.37K

Net cash flow from debt Issuance/repayment

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

-76.97%62.50K

--2.42M

--271.37K

Net cash flow from common stock issuance/repurchase

-100.00%0.00

482.68%33.01M

-1.15%4.92M

472.23%3.78M

-59.91%3.26M

13.44%5.67M

-56.40%4.98M

--660.44K

41.25%8.12M

--4.99M

--11.42M

-100.00%0.00

5649.88%5.75M

-100.00%0.00

--11.50M

--100.00K

--2.37M

--376.00K

--0.00

Proceeds from stock option exercised by employees

--0.00

4467.42%38.55K

-100.00%0.00

--844.00

--1.32K

2008.38%30.19K

--185.65K

----

-100.00%0.00

-92.04%1.43K

--0.00

-100.00%0.00

408.33%18.30K

--18.00K

--0.00

783.33%47.70K

--3.60K

--5.40K

----

Proceeds from issuance of warrants

----

--0.00

--572.65K

--328.92K

----

--0.00

-100.00%0.00

--0.00

--275.40K

--110.00K

--529.42K

--0.00

----

Net cash flow from other financing activities

63.20%-65.00K

-874.77%-2.00M

11.56%-118.70K

-83.57%-117.14K

44.86%-176.63K

26.08%-204.67K

97.90%-134.21K

-151.25%-63.81K

80.35%-320.34K

---276.89K

-880.92%-6.39M

107.10%124.51K

---1.63M

--0.00

-353.04%-651.58K

---1.75M

--0.00

-100.00%0.00

--257.50K

--2.00K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-101.91%-65.00K

468.60%31.05M

-0.89%4.80M

575.60%4.23M

-57.33%3.41M

15.78%5.46M

-3.58%4.85M

397.71%626.82K

93.89%7.99M

--4.72M

893.55%5.03M

-98.71%125.94K

997.37%4.12M

-100.00%0.00

-151.53%-633.28K

--9.76M

--375.40K

4.19%2.53M

352.90%1.23M

--2.43M

--271.37K

Net cash flow

Beginning cash balance

----

-9.82%8.66M

25.33%10.89M

-12.39%10.14M

31.33%10.86M

34.27%9.60M

42.36%8.69M

26.60%11.58M

9.03%8.27M

-34.70%7.15M

-56.59%6.10M

12.22%9.15M

-26.30%7.59M

3.56%10.95M

28.41%14.06M

--8.15M

--10.29M

1493.82%10.57M

1543.65%10.95M

--663.46K

--666.35K

Current period cash flow changes

----

1940.82%25.76M

-345.32%-2.23M

125.87%747.21K

-121.73%-718.77K

12.60%1.26M

-12.96%910.51K

5.03%-2.89M

112.07%3.31M

133.31%1.12M

133.61%1.05M

-151.43%-3.04M

172.77%1.56M

-1098.09%-3.36M

-723.01%-3.11M

--5.91M

---2.14M

-112.90%-280.83K

-12964.32%-378.21K

--2.18M

---2.90K

Effect of exchange rate changes

----

360.93%14.09K

41.71%-15.61K

-111.19%-1.04K

54.09%8.37K

132.19%3.06K

-304.13%-26.77K

190.88%9.29K

469.60%5.43K

-139.38%-9.49K

-56.14%13.12K

61.07%-10.22K

125.14%954.00

7.38%-3.97K

--29.90K

---26.26K

---3.79K

---4.28K

----

--0.00

----

Ending cash balance

----

216.78%34.41M

-9.82%8.66M

25.33%10.89M

-12.39%10.14M

31.33%10.86M

34.27%9.60M

42.36%8.69M

26.60%11.58M

9.03%8.27M

-34.70%7.15M

-56.59%6.10M

12.22%9.15M

-26.30%7.59M

3.56%10.95M

--14.06M

--8.15M

262.49%10.29M

1493.82%10.57M

--2.84M

--663.46K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Maia Biotechnology Inc Generate?



Maia Biotechnology Inc generated -18.84M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Maia Biotechnology Inc's Operating Cash Flow Change Year Over Year?



Maia Biotechnology Inc's operating cash flow increased by -20.00% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Maia Biotechnology Inc's Financing Cash Flow Changed?



Maia Biotechnology Inc used 17.91M in financing activities in the latest quarter.

What is free cash flow and why does it matter for MAIA?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.